Herzliya Medical Center
Tel: +972-9-959-4888
09:00-18:00
Effective treatment of metastatic melanoma in Israel carried out by experts at the Oncology Department of leading private hospital Herzliya Medical Center.
The application of innovative technologies and conservative and surgical treatment of metastatic melanoma, as well as early detection, have allowed HMC to achieve excellent results in survival and long-term remission in the majority of patients. Metastatic melanoma is also termed advanced melanoma or stage IV melanoma.
Metastatic cancers involve the secondary spread of cancers from their primary location, to other parts of the body via the lymph nodes.
Recurrence of melanoma is also possible to develop within 2cm of the initial melanoma scar. Metastatic cancers are harder to treat; therefore, early detection is imperative for a patient’s complete recovery.
Melanoma is a highly malignant tumor originating in the pigment cells (melanocytes) of the skin, mucous membranes and the retina of the eye (rarely). This type of cancer is highly invasive (penetrating) and has the ability and propensity for the early dissemination of metastases. The main routes of metastasis of melanoma are:
Metastatic melanoma develops in late diagnosis of melanoma, or by ineffective use of treatment methods. This highlights the importance of patients being diagnosed early for effective treatment of melanoma in Israel will help prevent the risk of secondary spread.
Modern methods of complex therapies, including the treatment of metastatic melanoma apply to cancer treatment in Israel:
It is possible to surgically remove single lymph nodes or main lymph node groups that are involved in the disease process. Typically, surgery is performed in conjunction with radiation therapy and medication; this increases the likelihood of destroying the malignant cells. Treatment of melanoma metastases in the lymph nodes is carried out under the control of high-precision diagnostic methods that are sensitive to metabolic changes of tissues using PET-CT scan.
In addition to surgical treatment, the possibility of a minimally invasive procedure using a high-frequency ablation of the tumor. Chemosensitivity of the tumor treated by hepatic artery chemoembolization. The high sensitivity of hepatocytes (liver cells) to radiation limits the use of irradiation of metastatic lesions; however, recently a technique of radiosurgery for inoperable metastatic melanoma to the liver was developed.
Recurring melanoma affects many organs and systems and requires a comprehensive approach in the diagnosis and selection of optimal treatment strategies. Herzliya Medical Center uses the results of recent discoveries of the world’s leading centers for the study of melanoma and guarantees an individual approach to the treatment of each patient, taking into account characteristics of the disease, response to previous therapy, and the presence of concomitant medical problems. The hospital’s main priority is to ensure the patient’s optimal health and remission from the disease.